Devices › Catheter, peripheral, atherectomy
Device brand name · Diamondback 360 orbital atherectomy system
Diamondback 360 Orbital Atherectomy System: medical device reports filed with FDA
241 reports name it, 2007–2015. Manufacturer given most often on reports: Cardiovascular Systems. Product code MCW.
- 241
- device reports naming the brand
- 0% of all MAUDE reports · about 13 a year
- 0
- reports, 12 months to August 2026
- 0 in the 12 months before
- 4.6%
- classified as malfunction
- 55.6% across the product code
- 3.3%
- classified as death, as reported
- 8 reports · not verified by FDA
241 medical device reports received by FDA name the brand "Diamondback 360 Orbital Atherectomy System" (diamondback 360 orbital atherectomy system); the manufacturer given most often on reports is Cardiovascular Systems; received from November 2007 to October 2015. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.
0 reports arrived in the 12 months to August 2026, and none in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (92.1%), malfunction (4.6%) and death (3.3%); across all catheter, peripheral, atherectomy reports (product code MCW) death is recorded in 1.8% and malfunction in 55.6%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are sticking (21.6%), difficult to remove (19.9%) and insufficient device problem information (15.4%). The patient problems coded most often are intimal dissection, vascular system (circulation), impaired and perforation of vessels. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
No report naming Diamondback 360 Orbital Atherectomy System was received in the five years to August 2026; the latest was received in October 2015.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 8,514 reports carrying product code MCW. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Sticking | 52 | 21.6% | 2.3% |
| Difficult to removethe device was hard to remove | 48 | 19.9% | 7.1% |
| Insufficient device problem information | 37 | 15.4% | 1.8% |
| Fracturea broken bone | 30 | 12.4% | 2.8% |
| Breakthe device broke | 28 | 11.6% | 15.6% |
| Detachment of device component | 28 | 11.6% | 2.3% |
| Device operates differently than expectedthe device behaved unexpectedly | 19 | 7.9% | 1.5% |
| Entrapment of device | 17 | 7.1% | 12.2% |
| Device, or device fragments remain in patient | 13 | 5.4% | 0.5% |
| Device, removal of (non-implant) | 12 | 5% | 0.8% |
| Failure to advance | 12 | 5% | 1.8% |
| Tip breakage | 9 | 3.7% | 0.7% |
| Kinkedthe tube or line kinked | 8 | 3.3% | 0.4% |
| Physical resistance | 8 | 3.3% | 0.6% |
| Bent | 7 | 2.9% | 0.2% |
| Replace | 7 | 2.9% | 0.8% |
| Migration or expulsion of device | 6 | 2.5% | 0.3% |
| Split | 6 | 2.5% | 0.1% |
| Improper or incorrect procedure or method | 5 | 2.1% | 0.7% |
| Material separation | 5 | 2.1% | 7.8% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Intimal dissection | 32 | 13.3% |
| Vascular system (circulation), impaired | 30 | 12.4% |
| Perforation of vessels | 27 | 11.2% |
| Therapy/non-surgical treatment, additional | 23 | 9.5% |
| Embolism | 21 | 8.7% |
| Device embedded in tissue or plaque | 20 | 8.3% |
| Occlusion | 20 | 8.3% |
| Nonresorbable materials, unretrieved in body | 13 | 5.4% |
| Surgical procedure | 12 | 5% |
| Surgical procedure, additional | 11 | 4.6% |
| Vascular dissection | 11 | 4.6% |
| Foreign body, removal of | 10 | 4.1% |
| Hemorrhage/blood loss/bleeding | 9 | 3.7% |
| Deaththe patient died; cause not stated by this term | 7 | 2.9% |
| Thrombus | 7 | 2.9% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Diamondback 360 Orbital Atherectomy System | Product code MCW | All MAUDE reports |
|---|---|---|---|
| Reports | 241 | 8,514 | 26,136,888 |
| Share of that pool | — | 2.8% | 0% |
| Classified as death, per 1,000 reports | 33 | 18 | 9 |
| Classified as injury | 92.1% | 40.9% | 36.2% |
| Classified as malfunction | 4.6% | 55.6% | 62.3% |
| Filed by the manufacturer | 99.2% | 96.1% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code MCW
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Rotarex | 1,340 | 373 | 0.7% |
| JETSTREAM XC Atherectomy Catheter | 741 | 71 | 0.3% |
| Diamondback 360 Peripheral Orbital Atherectomy System | 676 | 0 | 0.9% |
| Jetstream Xc | 590 | 44 | 0% |
| Hawkone 6fr | 566 | 30 | 0% |
| Peripheral Rotalink Plus | 158 | 1 | 1.9% |
| JETSTREAM Atherectomy Catheter | 151 | 32 | 0.7% |
| Crosser Recanalization Catheter | 159 | 0 | 1.3% |
| Rotalink Catheter | 154 | 0 | 13% |
| Diamondback 360 Coronary Orbital Atherectomy System | 1,512 | 0 | 15.7% |
| Crosser Cto Recanalization Catheter | 362 | 0 | 0.3% |
| Fogarty Arterial Embolectomy Catheter | 1,165 | 37 | 0.2% |
| Rotablator Guide Wire | 352 | 0 | 3.7% |
| Crosser Cto Recanalization Catheters | 223 | 0 | 0% |
| Datascope | 356 | 0 | 7.3% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Diamondback 360 Orbital Atherectomy System reports
How many FDA reports name Diamondback 360 Orbital Atherectomy System?
241 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 0 in the latest 12 months.
What kinds of events are reported?
injury (92.1%), malfunction (4.6%) and death (3.3%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
sticking (21.6%), difficult to remove (19.9%), insufficient device problem information (15.4%), fracture (12.4%) and break (11.6%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (99.2%) and voluntary reports (0.8%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Diamondback 360 Orbital Atherectomy System was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.